Sort
23,748 grants matching “melanoma”
Project 2: The Impact of Immunotherapy on Human Vaccination
$462,053E. John Wherry · Massachusetts General Hospital · U19 · FY2023 · AI
HSP70 and melanoma
$462,002Maureen E Murphy · Wistar Institute · R01 · FY2015 · CA
The Development of Thermally-activated Metalloenediynes for Cancer Therapy
$461,916Joseph R Dynlacht · Indiana University Indianapolis · R01 · FY2019 · CA
Using Nonclassical Estrogen Signaling to Prevent Melanoma
$461,852Todd W Ridky · University Of Pennsylvania · R01 · FY2019 · CA
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges
$461,828Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · NS
Computer aided diagnosis of cancer metastases in the brain
$461,828Xiaoyin Xu · Brigham And Women'S Hospital · R01 · FY2016 · LM
Natural Language Processing Platform for Cancer Surveillance
$461,775Guergana K. Savova · Boston Children'S Hospital · UG3 · FY2019 · CA
Apigenin restores TSP-1 expression in UVB-irradiated keratinocytes
$461,702Olga Valery Volpert · Northwestern University At Chicago · R01 · FY2016 · CA
Interplay between tumor and microenvironment in bone metastasis
$461,537Paul B Fisher · Virginia Commonwealth University · R01 · FY2023 · CA
Interplay between tumor and microenvironment in bone metastasis
$461,537Paul B Fisher · Virginia Commonwealth University · R01 · FY2022 · CA
MAINLINE HEALTH CCOP
$461,522Lankenau Institute For Medical Research · U10 · FY2004 · CA
A novel preclinical model of spontaneous metastasis
$461,518Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Regulation of metastatic progression by an endothelial-derived factor
$461,474Sohail F. Tavazoie · Rockefeller University · R01 · FY2022 · CA
Computational Methods for Identifying Non-coding Cancer Drivers
$461,451Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$461,363Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Targeting UHRF1 in combinational immunotherapy
$461,315Xiao-Fan Wang · Duke University · R01 · FY2022 · CA
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
$461,149Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Limiting UV-induced genome instability with self-cycling antioxidant reagents
$461,056Edward J Merino · University Of Cincinnati · R15 · FY2019 · ES
Targeting UHRF1 in combinational immunotherapy
$461,025Xiao-Fan Wang · Duke University · R01 · FY2023 · CA
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
$460,837Duane A. Mitchell · University Of Florida · R01 · FY2015 · CA
Role of Formylpeptide Receptors in Host Defense
$460,819Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Lymph node-targeted codelivery of albumin-binding peptide antigens and di-adjuvant for melanoma combination immunotherapy
$460,692Guizhi Zhu · Virginia Commonwealth University · R01 · FY2022 · CA
PHARMACOLOGICAL TARGETING OF GALPHA SUBUNITS IN DISEASE
$460,566Kendall Jay Blumer · Washington University · R01 · FY2024 · GM
PHARMACOLOGICAL TARGETING OF GALPHA SUBUNITS IN DISEASE
$460,566Kendall Jay Blumer · Washington University · R01 · FY2022 · GM
PHARMACOLOGICAL TARGETING OF GALPHA SUBUNITS IN DISEASE
$460,566Kendall Jay Blumer · Washington University · R01 · FY2023 · GM